Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts

Challenges in drug delivery to tumors of the central nervous system: An overview of pharmacological and surgical considerations

(2012) Laura P. Serwer et al.   ADVANCED DRUG DELIVERY REVIEWS

Investigation of intravenous delivery of nanoliposomal topotecan for activity against orthotopic glioblastoma xenografts

(2011) L. P. Serwer et al.   NEURO-ONCOLOGY

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience

(2009) Amy Y. Grahn et al.   JOURNAL OF NEURO-ONCOLOGY

Optimized cannula design and placement for convection-enhanced delivery in rat striatum

(2009) Dali Yin et al.   JOURNAL OF NEUROSCIENCE METHODS

Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging

(2008) Peter J. Dickinson et al.   JOURNAL OF NEUROSURGERY